Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Coya Therapeutics
Biotech
After delay, Coya receives FDA go-ahead for phase 2 ALS trial
The agency previously alerted Coya that it would miss the July 30 deadline for a decision on the IND application due to limited resources.
Darren Incorvaia
Aug 25, 2025 11:04am
FDA delays hit clinical trial launch decisions
Jul 30, 2025 10:29am
Coya shares data on IL-2 prospect in small Alzheimer's study
Oct 29, 2024 7:55am
BioMarin builds exec team with biotech vets—Chutes & Ladders
Aug 23, 2024 8:30am
Coya taps familiar friend Dr. Reddy's to commercialize ALS med
Dec 6, 2023 11:20am
Coya deems dementia drug R&D plan 'premature,' switches focus
Jun 12, 2023 9:00am
